Latvia vs Myanmar: Death rate from pneumonia
Latvia
24.17 deaths per 100,000 people
in 2021
Myanmar
25.06 deaths per 100,000 people
in 2021
Latvia rank
111th
Myanmar rank
110th
Death rate from pneumonia over time
- Latvia
- Myanmar
How they compare
Myanmar currently reports 25.06 deaths per 100,000 people against 24.17 deaths per 100,000 people in Latvia, a difference of 0.89 deaths per 100,000 people.
Across all 22 years both countries report, Myanmar has been ahead every year.
Latvia ranks 111th and Myanmar ranks 110th of 194 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.04 deaths per 100,000 people | 44.89 deaths per 100,000 people | 24.85 deaths per 100,000 people | Myanmar |
| 2010s | 21.37 deaths per 100,000 people | 32.06 deaths per 100,000 people | 10.69 deaths per 100,000 people | Myanmar |
| 2020s | 22.74 deaths per 100,000 people | 26.49 deaths per 100,000 people | 3.75 deaths per 100,000 people | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from pneumonia, Latvia or Myanmar?
- Myanmar, at 25.06 deaths per 100,000 people against 24.17 deaths per 100,000 people in Latvia as of 2021.
- What is the difference in death rate from pneumonia between Latvia and Myanmar?
- 0.89 deaths per 100,000 people, with Myanmar ahead.
- How many years of comparable data are there for Latvia and Myanmar?
- 22 years are reported by both, from 2000 to 2021.
- How do Latvia and Myanmar rank globally for death rate from pneumonia?
- Latvia ranks 111th and Myanmar ranks 110th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from pneumonia. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from lower respiratory infections in both sexes, per 100,000 people.